ArticleNeoplasia (New York, N.Y.)2007

PEGylated DX-1000: pharmacokinetics and antineoplastic activity of a specific plasmin inhibitor.

Laetitia Devy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.